REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/08/2026
Back to search
Official data from USPTO
INPHARMA RESEARCH · DEVELOP PRODUCE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
06/09/2026
Trademark type
Combined
Nice classes
5
Filing date
09/30/2019
Registration date
06/08/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/08/2021
Last transaction
06/09/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
09
Owner location
IT
Examiner
VAN DEN ABEELEN, DEREK C
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a design of four rectangles with two curved corners each, wherein the top left rectangle is in gold and is larger than the other three rectangles, and the other three rectangles are in blue, and wherein the rectangles design is to the left of the wording "INPHARMA", wherein the wording "IN" is in gold and "PHARMA" is in blue, above the wording "RESEARCH DEVELOP PRODUCE" in blue with blue dots between this wording.
Holders and representatives
Holders
Inpharma S.p.A.
Representatives
Francesco Braga Perani & Partners S.p.A.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Foodstuffs and dietetic substances for medical and veterinary purposesdietary supplementsfood grade products being capsules sold empty for pharmaceuticalsinfant food for medical purposesOrganic food supplementsorganic dietary supplementspowder food supplementsliquid food supplementsdietary supplements that are sold in a container cap for subsequent delivery into liquidsnewborn food supplementsinfant food supplementswellness dietary supplementsnatural dietary supplements for the treatment of the mental healthnutritionally complete dietetic foods with a standard nutrient formulation adapted for medical purposesnutritionally complete dietetic foods with a nutrient-adapted formulation specific for a diseasenutritionally incomplete dietetic foods with a standard formulation or a nutrient-adapted formulation specific for a disease; dietetic and nutritional preparations for medical use; infant formula; dietetic substances for babies for medical purposes; dietary supplements for infants; dietary supplements for humans and animals; food supplements; dietary food supplementsnot for medical purposes; dietary supplements; nutritional supplements; dietary supplement drink mixes; dietary supplemental drinks; dietetic beverages adapted for medical purposes; multi-vitamin preparations; vitamins and vitamin preparations; dietary supplements for athletes; powdered nutritional supplement drink mix; dietetic foodstuffs for medical purposesdietary supplements; probiotic supplements; prebiotic supplements; probiotic bacterial formulations for medical useprobiotic supplements; probiotic preparations for medical use to help maintain a natural balance of flora in the digestive system; milk ferments for pharmaceutical purposes; pharmaceutical preparations and substances for treating constipation or diarrhoea; pharmaceutical preparations and substancesAntioxidantsnutritional supplements for boosting energyMultivitaminsSleeping pills/tabletsImmunostimulantsoral Rehydration saltsVitaminsskin Enhancers being medicated skin care preparationsNasal spraysAmino acidsAntiemetic preparationsnutritional supplements consisting primarily of ironAnti-inflammatorieslozenges to relieve sore throatcough syrupsanti-obesity diet capsules; medicinal preparations and substances for treating constipation or diarrhoea; medicinal preparations and substancesnutritional supplements for boosting energyMultivitaminsSleeping pills/tabletsImmunostimulantsoral Rehydration saltsVitaminsskin Enhancers being medicated skin care preparationsNasal spraysAmino acidsAntiemetic preparationsnutritional supplements consisting primarily of ironAnti-inflammatorieslozenges to relieve sore throatcough syrupsanti-obesity diet capsules; antibacterial substances for medical purposes; diagnostic substances for medical use; astringents for medical purposes; pharmaceutical antiallergic preparations and substances; bactericides; medical devices based on substancesdelivery agents in the form of dissolvable films that facilitate the delivery of nutritional supplementsnasal sprays for cold symptomssprays to relieve sore throat
Publications
History of USPTO decisions and trademark events.
31 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/30/2026
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/24/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/28/2021
FIMP
FINAL DISPOSITION PROCESSED
09/27/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/08/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
06/08/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/23/2021
PUBO
PUBLISHED FOR OPPOSITION
03/23/2021
GPNX
NOTIFICATION PROCESSED BY IB
03/21/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/03/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/03/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/03/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/18/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
02/18/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/18/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
02/18/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/18/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/09/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/09/2021
ALIE
ASSIGNED TO LIE
02/06/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/03/2020
RFNT
REFUSAL PROCESSED BY IB
05/23/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/03/2020
RFRR
REFUSAL PROCESSED BY MPU
05/03/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/22/2020
CNRT
NON-FINAL ACTION WRITTEN
04/21/2020
MAFR
APPLICATION FILING RECEIPT MAILED
04/04/2020
DOCK
ASSIGNED TO EXAMINER
03/31/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/31/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/26/2020
Continuous trademark protection
Get notified about every new filing that threatens INPHARMA RESEARCH · DEVELOP PRODUCE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.